Solasta Ventures logo

Solasta Ventures

North America, Massachusetts, United States, Boston

Description

Solasta Ventures is investing in healthcare and life sciences for a brighter future.

Investor Profile

Solasta Ventures has made 31 investments, with 2 in the past 12 months and 3% as lead.

Stage Focus

  • Series B (39%)
  • Series C (19%)
  • Series A (16%)
  • Series Unknown (10%)
  • Post Ipo Equity (10%)
  • Series D (6%)

Country Focus

  • United States (90%)
  • New Zealand (3%)
  • Canada (3%)
  • United Kingdom (3%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Life Science
  • Oncology
  • Biopharma
  • Pharmaceutical
  • Genetics
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Solasta Ventures frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 3
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
MRL Ventures Fund
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
Tekla Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
TPG Biotech
North America, California, United States, San Francisco
Co-Investments: 3
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 3
SL
North America, District of Columbia, United States, Washington
Co-Investments: 4
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 5
Livzon Pharmaceutical Group
Asia, Guangdong, China, Zhuhai
Co-Investments: 3

Which angels does Solasta Ventures often collaborate with?

RB
North America, Virgin Islands, United States
Shared Deals: 1
PT
North America, California, United States, San Francisco
Shared Deals: 1
JB
North America, Washington, United States, Seattle
Shared Deals: 1
FB
North America, New York, United States, New York
Shared Deals: 1
SA
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Solasta Ventures?

Maxion Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Maxion Therapeutics helps in learning transformative therapies.

Information TechnologyTherapeutics
Series AMar 17, 2025
Amount Raised: $75,016,620
Axonis Therapeutics

Boston, Massachusetts, United States

Axonis Therapeutics is a neuro-focused biotechnology company that focuses on the development of novel neuromedicines.

BiotechnologyLife ScienceMedical
Series AOct 30, 2024
Amount Raised: $115,000,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series UnknownNov 16, 2023
Amount Raised: $37,398,371
ReCode Therapeutics

Dallas, Texas, United States

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

BiopharmaBiotechnologyGeneticsPharmaceutical
Series BSep 19, 2023
Amount Raised: $50,000,000
Boxhub

Toronto, Ontario, Canada

Leading online platform on a mission to revolutionize the way intermodal shipping containers are traded, transported, and used.

E-CommerceIndustrialInternetLast Mile TransportationLogisticsShippingSupply Chain Management
Series AJun 28, 2023
Amount Raised: $12,400,000
Prime Roots

Berkeley, California, United States

Prime Roots makes mycelium based meats products focusing on deli and charcuterie products.

Alternative ProteinFood and BeverageFood ProcessingRestaurants
Series BMay 15, 2023
Amount Raised: $30,000,000
Ensoma

Boston, Massachusetts, United States

Ensomaa is a genomic medicine company that develops on one-time in vivo treatments for immuno-oncology and other therapeutic applications.

BiotechnologyGeneticsLife ScienceMedicalOncologyTherapeutics
Series BJan 5, 2023
Amount Raised: $85,000,000
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
Tibit Communications

Petaluma, California, United States

TiBiT Communications offers a disruptive technology that will fundamentally change the way broadband access.

Information TechnologySoftwareTelecommunications
Series CJun 23, 2022
Amount Raised: $30,000,000
Carbon Biosciences

Lexington, Massachusetts, United States

Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.

BiotechnologyProduct ResearchTherapeutics
Series AJun 21, 2022
Amount Raised: $38,000,000